LRRK2 c.86dup ;(p.Q31Tfs*78)

Variant ID: 12-40619017-A-AG

NM_198578.3(LRRK2):c.86dup;(p.Q31Tfs*78)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.

Movement Disorders : Official Journal Of The Movement Disorder Society
Simuni, Tanya T; Brumm, Michael C MC; Uribe, Liz L; Caspell-Garcia, Chelsea C; Coffey, Christopher S CS; Siderowf, Andrew A; Alcalay, Roy N RN; Trojanowski, John Q JQ; Shaw, Leslie M LM; Seibyl, John J; Singleton, Andrew A; Toga, Arthur W AW; Galasko, Doug D; Foroud, Tatiana T; Nudelman, Kelly K; Tosun-Turgut, Duygu D; Poston, Kathleen K; Weintraub, Daniel D; Mollenhauer, Brit B; Tanner, Caroline M CM; Kieburtz, Karl K; Chahine, Lana M LM; Reimer, Alyssa A; Hutten, Samantha S; Bressman, Susan S; Marek, Kenneth K; ,
Publication Date: 2020-05

Variant appearance in text: LRRK2: 84_85insG
PubMed Link: 32073681
Variant Present in the following documents:
  • Main text
View BVdb publication page